American Financial Tribune
SEE OTHER BRANDS

Informing on finance and banking news in the United States

American Financial Tribune: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Financial Tribune.

Press releases published on May 24, 2025

TechTarget, Inc. Investor News: If You Have Suffered Losses in TechTarget, Inc. (NASDAQ: TTGT), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

TechTarget, Inc. Investor News: If You Have Suffered Losses in TechTarget, Inc. (NASDAQ: TTGT), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

NEW YORK, May 24, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of TechTarget, Inc. (NASDAQ: TTGT) resulting from allegations that …

GoHealth, Inc. Investor News: If You Have Suffered Losses in GoHealth, Inc. (NASDAQ: GOCO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

GoHealth, Inc. Investor News: If You Have Suffered Losses in GoHealth, Inc. (NASDAQ: GOCO), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

NEW YORK, May 24, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of GoHealth, Inc. (NASDAQ: GOCO) resulting from allegations that GoHealth …

$HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of Star Equity Holdings, Inc. (NASDAQ: STRR)

$HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of Star Equity Holdings, Inc. (NASDAQ: STRR)

NYC, May 24, 2025 (GLOBE NEWSWIRE) -- NEW YORK, May 24, 2025 / GlobeNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde …

$HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of Vigil Neuroscience, Inc. (NASDAQ: VIGL)

$HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of Vigil Neuroscience, Inc. (NASDAQ: VIGL)

NYC, May 24, 2025 (GLOBE NEWSWIRE) -- NEW YORK, May 24, 2025 / GlobeNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde …

New Insights Released on Evolving Role of Real Estate Agents in the Age of Algorithms

New Insights Released on Evolving Role of Real Estate Agents in the Age of Algorithms

LOS ANGELES, CA, UNITED STATES, May 23, 2025 /⁨EINPresswire.com⁩/ -- In a rapidly evolving marketplace where algorithms rule search engines and AI chatbots dominate first impressions, the question real estate professionals must ask themselves is this: How …

TechTarget, Inc. Investor News: If You Have Suffered Losses in TechTarget, Inc. (NASDAQ: TTGT), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

TechTarget, Inc. Investor News: If You Have Suffered Losses in TechTarget, Inc. (NASDAQ: TTGT), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

NEW YORK, May 24, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of TechTarget, Inc. (NASDAQ: TTGT) resulting from allegations that …

Mineralys Therapeutics Announces Late-Breaking Presentation of Data from the Launch-HTN Pivotal Trial of Lorundrostat in Uncontrolled or Resistant Hypertension at 34th European Meeting on Hypertension and Cardiovascular Protection (ESH 2025)

Mineralys Therapeutics Announces Late-Breaking Presentation of Data from the Launch-HTN Pivotal Trial of Lorundrostat in Uncontrolled or Resistant Hypertension at 34th European Meeting on Hypertension and Cardiovascular Protection (ESH 2025)

– Largest hypertension trial of an aldosterone synthase inhibitor to date demonstrated the efficacy of lorundrostat in over 1,000 participants with uncontrolled or resistant hypertension in a real-world setting – – Lorundrostat 50 mg dosed once daily …

Vorläufige Ergebnisse von Merus zu Petosemtamab mit Pembrolizumab zeigen robuste Wirksamkeit und Dauerhaftigkeit bei der Erstlinienbehandlung von PD-L1-positivem r/m HNSCC

Vorläufige Ergebnisse von Merus zu Petosemtamab mit Pembrolizumab zeigen robuste Wirksamkeit und Dauerhaftigkeit bei der Erstlinienbehandlung von PD-L1-positivem r/m HNSCC

- 63%ige Ansprechrate bei 24 auswertbaren Patienten beobachtet - 79%ige Gesamtüberlebensrate nach 12 Monaten; 9 Monate medianes progressionsfreies Überleben - Telefonkonferenz am Donnerstag, 22. Mai, um 17:30 Uhr (Eastern Time) UTRECHT, Niederlande, und …

Les données intermédiaires du pétosemtamab de Merus en association avec le pembrolizumab démontrent une réelle efficacité et une bonne durabilité dans le traitement de 1re ligne contre le CETC r/m PD-L1+

Les données intermédiaires du pétosemtamab de Merus en association avec le pembrolizumab démontrent une réelle efficacité et une bonne durabilité dans le traitement de 1re ligne contre le CETC r/m PD-L1+

- Taux de réponse de 63 % observé chez les 43 patients évaluables - Taux de survie général de 79 % au bout de 12 mois ; survie sans progression de niveau moyen à 9 mois - Conférence téléphonique le jeudi 22 mai à 17 h 30 heure de l’Est UTRECHT, Pays-Bas et …

RCAT Investor Notice: Robbins LLP Informs Stockholders of the Red Cat Holdings, Inc. Class Action

RCAT Investor Notice: Robbins LLP Informs Stockholders of the Red Cat Holdings, Inc. Class Action

SAN DIEGO, May 23, 2025 (GLOBE NEWSWIRE) -- Robbins LLP informs stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Red Cat Holdings, Inc. (NASDAQ: RCAT) securities between March 18, 2022 and January 15, …

FanRoom LIVE Reaches Show Milestone Garnering between 6 Million and 9 Million Views per Show as It Begins Its Star-Studded 2025 Season

FanRoom LIVE Reaches Show Milestone Garnering between 6 Million and 9 Million Views per Show as It Begins Its Star-Studded 2025 Season

LOS ANGELES, CA, May 23, 2025 (GLOBE NEWSWIRE) -- FanRoom LIVE kicked off its 2025 season and sixth year with STRANGER THINGS star Cara Buono who participated in the renown Virtual Meet …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service